Autoimmune Disease Diagnosis Market

Autoimmune disease diagnostics market is driven by growth in public awareness for autoimmune disorders, improved laboratory techniques and automation, growth in partnerships between clinical laboratories and physicians, rise in incidence of diseases such as Graves and Hashimoto's Thyroid Disease and rheumatoid arthritis.

The global autoimmune disease diagnosis market accounted for US$ 4.1 billion in 2020 and is estimated to be 6.3 billion by 2025 and is anticipated to register a CAGR of 7.5%. The report. "Global Autoimmune Disease Diagnosis Market, By Product (Consumables & Assay Kits and Instruments), By Test Type (Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test, and Other Tests), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, and Other Diseases), By End User (Clinical Laboratories, Hospitals, and Other End Users), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”.

Key Highlights:

• On March 2020, Siemens Healthiness and the Marienhaus Hospital Group, based in Waldbreitbach, have developed a ten-year technology partnership—involving an option to extend for an extra five years. Siemens Healthineers is launching a digital strategy for the Marienhaus Group that will eventually interconnect 18 hospitals and streamline clinical processes.
• On March 2020, Siemens Healthiness announced market launch of the teamplay digital health platform. With this teamplay digital health platform Siemens Healthineers paves the way for healthcare providers´ digital transformation – enabling easy access to solutions for clinical, operational & shared decision support.
• On September 2019, Siemens Healthiness started a future-ready Medical Imaging manufacturing facility in India. The next-gen facility collocated with the company’s R&D center at Bengaluru provides solutions from advanced therapies and diagnostic imaging.

Analyst View:

Growing awareness about autoimmune diseases

Growing awareness about autoimmune diseases through programs of education, research, support, and advocacy is a key factor driving the utilized rates of autoimmune disease diagnostics, worldwide. The U.S. has the highest prevalence’s of autoimmune diseases, whereas around 50 million patients suffer from autoimmune diseases. According to study reported by Arthritis Foundation, in 2017 nearly 54.4 million adults in the U.S. suffer from diagnosed arthritis. According to the International Diabetes Federation (IDF) report of the 2017, around 425 million adults (20-79 years) were suffering from diabetes, and by 2045 this number might increase to 629 million, across the globe. NGOs and government organizations aims to increase awareness about the socioeconomic impact of autoimmunity by driving and facilitating collaboration in the areas of education, research, public awareness, and patient services in an ethical, efficient, and effective manner. The other factors, such as partnerships with physicians and clinical laboratories, improved laboratory automation, and technological advancements, are fueling the autoimmune disease diagnostics market.

Increasing collaboration between market players

The growing partnerships between companies involved in autoimmune disease diagnostics market is useful for technology transfer, thereby increasing the availability of diagnostic systems. For example in 2015, Sengenics acquired Oxford Gene Technology’s protein array technology. This acquisition was useful in the diagnosis of various autoimmune conditions.

Key Market Insights from the report:        

The global autoimmune disease diagnosis market accounted for US$ 4.1 billion in 2020 and is estimated to be 6.3 billion by 2025 and is anticipated to register a CAGR of 7.5%. The market report has been segmented on the basis of product, test type, disease, end-user, and region.

• By product, the consumables & assay kits segment is projected to expand at the highest growth rate throughout the forecast period. This is attributed mainly due to increasing incidence of autoimmune disease and the growing number of product launches/approvals.
• By test type, the routine laboratory tests segment is expected to witness the largest CAGR over the forecast period. This can primarily be attributed to the advanced healthcare infrastructure coupled with growing prevalence of autoimmune diseases in the region.
• By disease, the target market is segmented into rheumatoid arthritis, systemic lupus erythematosus, sjögren’s syndrome, thyroiditis, scleroderma, and other diseases
• By end-user, the target market is segmented into clinical laboratories, hospitals, and other end users.
• By region, North America account the highest market share of over 40.0% in 2016, mainly due to the presence of favorable regulations & initiatives undertaken by the AARDA, launch of the Affordable Care Act, and high prevalence of disease in the region.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Global-Autoimmune-Disease-Diagnosis-Market-4264

Competitive Landscape:

The prominent player operating in the global autoimmune disease diagnosis market includes Thermo Fisher Scientific, Siemens Healthcare Private Limited, Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., SQI Diagnostics Inc., Quest Diagnostics, EUROIMMUN AG, INOVA Diagnostics, Inc., and Bio-Rad Laboratories, Inc.

The market provides detailed information regarding industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory framework across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included into the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

• Explains an overview of the product portfolio, including product development, planning, and positioning
• Explains details about key operational strategies with focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
• Detailed analysis of the market revenue over the forecasted period.
• Examining various outlooks of the market with the help of Porter’s five forces Analysis, PEST & SWOT Analysis.
• Study on the segments that are anticipated to dominate the market.
• Study on the regional analysis that is expected to register the highest growth over the forecast period

Key Topics Covered

1. Introduction

• Study Deliverables
• Study Assumptions
• Scope of the Study

2. Research Methodology
3. Executive Summary

• Opportunity Map Analysis
• Market at Glance
• Market Share (%) and BPS Analysis, by Region
• Competitive Landscape
• Heat Map Analysis 
• Market Presence and Specificity Analysis

4. Investment Analysis
5. Competitive Analysis

To know more

Contact Us:

Sales

Prophecy Market Insights

Email- sales@prophecymarketinsights.com

Article source: https://article-realm.com/article/Arts-Entertainment/Celebrities/30223-Autoimmune-Disease-Diagnosis-Market.html